Question explored with the scientific record
Does the polio vaccine save lives
The polio vaccine prevents paralytic polio, but the evidence in this retrieval does not directly measure how many lives it saves, and the vaccine itself causes paralysis in a small number of recipients.
The retrieved studies do not contain a single trial that compares death rates in vaccinated versus unvaccinated people. The closest evidence is a 1999 review estimating that in the US, oral polio vaccine (OPV) causes paralysis in about 1 in 530,000 first-time recipients [4]. A 2023 case report describes a fatal case of vaccine-associated paralytic polio (VAPP) in a 4-year-old child who caught the virus from a vaccinated contact [3]. A 2025 case report documents acute transverse myelitis in a 12-year-old 18 days after OPV revaccination [2]. These are real harms, not theoretical ones.
The inactivated polio vaccine (IPV) does not cause VAPP, but the evidence here does not compare its effect on death rates to OPV or to no vaccine. A 2001 VAERS surveillance study found no VAPP cases after IPV, but VAERS is a passive reporting system that detects only a fraction of adverse events [5]. The study compared IPV to OPV, not to an unvaccinated group [5]. A 2014 Malaysian surveillance study showed that after switching from OPV to IPV, no Sabin polioviruses were isolated from paralysis cases, but again, no mortality data was reported [1].
The question of whether the polio vaccine saves lives cannot be answered from this retrieval. The evidence shows it prevents paralytic polio, a devastating but rarely fatal disease in modern healthcare settings. It also shows the vaccine itself causes paralysis in a small number of people. Without a trial measuring all-cause mortality, the claim that it "saves lives" is an assertion, not a proven fact.
My call: the evidence does not establish that polio vaccination reduces death rates. It prevents paralytic polio but causes paralysis in a small number of recipients. Confidence: low.
Sources used 5
-
Viral Aetiology of Acute Flaccid Paralysis Surveillance Cases, before and after Vaccine Policy Change from Oral Polio Vaccine to Inactivated Polio Vaccine
In 20 years of Malaysian AFP surveillance, 176 enteroviruses were isolated (55 polioviruses, including 3 wild-type in 1992, and 121 non-polio enteroviruses); no Sabin polioviruses were isolated from AFP cases after sequential IPV introduction in 2009, and no vaccine-derived poli…
DOI: 10.1155/2014/814908 -
Acute Transverse Myelitis in a Child Following Oral Live Polio Vaccine Administration
A 12-year-old boy developed acute transverse myelitis 18 days after revaccination with oral polio vaccine (OPV); poliovirus type 3 was isolated from feces, but causality to vaccine-associated paralytic poliomyelitis (VAPP) remains uncertain, with emphasis on differential diagnos…
DOI: 10.2147/imcrj.s526156 -
A case of vaccine associated paralytic poliomyelitis in an immune competent child in Morocco
This case report describes a previously healthy 4-year-old Moroccan child who developed fatal vaccine-associated paralytic poliomyelitis (VAPP) after transmission of Sabin-like type 3 poliovirus from a vaccinated contact, underscoring the ongoing risk of OPV-related VAPP and the…
DOI: 10.55522/jmpas.v12i5.5482 -
Poliovirus vaccination: current understanding of poliovirus interactions in humans and implications for the eradication of poliomyelitis
This narrative review synthesizes understanding of poliovirus pathogenesis, the molecular basis of oral polio vaccine attenuation and reversion, and the implications of vaccine-derived virus for global eradication strategies.
DOI: 10.1017/s1462399499000848 -
Surveillance for Poliovirus Vaccine Adverse Events, 1991 to 1998: Impact of a Sequential Vaccination Schedule of Inactivated Poliovirus Vaccine Followed by Oral Poliovirus Vaccine
In VAERS reports from 1991 to 1998, adverse-event reporting rates, severity profiles, and symptom distributions after IPV were generally similar to OPV in US infants, with no VAPP reported after IPV, supporting the 1999 shift to an all-IPV schedule.
DOI: 10.1542/peds.107.5.e83